Organization
Vaccinex, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Vaccinex, Inc.
... ROCHESTER, N.Y., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the discovery and development ...
... ROCHESTER, N.Y., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the development of therapeutic ...
... technologies and development solutions for drugs, biologics and consumer health products, and Vaccinex, Inc., a clinical-stage biotechnology company engaged in the discovery and development of ...
... ROCHESTER, N.Y., Oct. 26, 2017 (GLOBE NEWSWIRE) -- Vaccinex Inc. today announced the dosing of the first patient in a Phase ...
... and metabolic activity - ROCHESTER, N.Y., April 24, 2017 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the discovery and development ...
... ROCHESTER, N.Y., Oct. 06, 2016 (GLOBE NEWSWIRE) -- Vaccinex, Inc. announced today it has entered into a collaboration agreement with Merck ...
... announced it has entered into a License Agreement (the "Agreement") with Vaccinex Inc. ("Vaccinex"). Under the terms of the Agreement, Vaccinex will have the right ...
... ROCHESTER, N.Y., Sept. 09, 2016 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a clinical-stage biotechnology company engaged in the discovery and development of ...
... ROCHESTER, N.Y., Aug. 23, 2016 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a clinical-stage biotechnology company engaged in the discovery and development of ...
... ROCHESTER, N.Y., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Vaccinex, Inc. today announced that the U.S. Food and Drug Administration (FDA) has ...
... SL, Teva Pharmaceutical Industries Limited, TyrNovo Ltd., Ultragenyx Pharmaceutical Inc., uniQure N.V., Vaccinex, Inc., Vertex Pharmaceuticals Incorporated, VistaGen Therapeutics , Inc., VivaCell Biotechnology Espana S.L., ...
... ROCHESTER, N.Y., Oct. 20, 2015 (GLOBE NEWSWIRE) -- Vaccinex Inc., a clinical-stage biotechnology company engaged in the discovery and development of ...
... Vaccinex announces groundbreaking preclinical data demonstrating an immunomodulatory role for anti-SEMA4D antibody blockade ...
... ROCHESTER, N.Y., Dec. 12, 2014 /PRNewswire/ -- Vaccinex Inc., a clinical-stage biotechnology company engaged in the discovery and development of ...
... Vaccinex provides an update on its VX15/2503 Phase 1 clinical trial in cancer ...
... Vaccinex to present its ActivMAb® Antibody Discovery Technology at the 2014 IBC Antibody ...
... the invention: "METHODS FOR THE TREATMENT OF B CELL-MEDIATED INFLAMMATORY DISEASES." Applicants: VACCINEX INC. (US). Inventors: Ernest S. Smith (US) and Maurice Zauderer (US). According ...
Subscribe now for full coverage on Vaccinex, Inc.
Start My Free Trial